Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke

Archives of Neurology

Volumn 54, Issue 12, 1997, Pages 1466-1474

  Tilley, Barbara C ^a   Lyden, Patrick D ^c   Brott, Thomas G ^d   Lu, Mei ^a   Levince, Steven R ^b   Welch, K M A ^b  

^a HENRY FORD HEALTH SCIENCES CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DOUBLE BLIND PROCEDURE; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TOTAL QUALITY MANAGEMENT;

EID: 0030808769     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550240020008     Document Type: Article

References (27)

1. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12:723-725.
2. Barsan WC, Brott TG, Olinger CP, et al. Early treatment for acute ischemic stroke. Ann Intern Med. 1989;222:449-451.
3. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581-1587.
4. Olinger CP, Brott TG, Barsan WC, et al. Double-blind randomized placebo-controlled study of ancrod as therapy for acute cerebral infarction. Stroke. 1988; 19:133.
5. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
6. Fisher M, Pessin MS, Furlan AJ, ECASS. Lessons for future thrombolytic stroke trials. JAMA. 1995;274:1058-1059.
7. Scholtes PR, Joiner BL, Braswell B, Finn L, Hacquebord H, Little K, et al. The Team Handbook: How to Use Teams to Improve Quality. Madison, Wis: Joiner Associates Inc: 1990.
8. Deming WE. The New Economics for Industry, Education, Government. Cambridge, Mass: Massachusetts Institute of Technology, Center for Advanced Engineering Study; 1993.
9. Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med. 1989;320:53-56.
10. Sahney VK, Warden GL. The process of total quality management in health care. Front Health Serv Manage. 1991;7:2-41.
11. Berwick DM, Godfrey AB, Roessner J. Curing Health Care: New Strategies for Quality Improvement: a Report on the National Demonstration Project on Quality Improvement in Health Care. San Francisco: Jossey-Bass;1990.
12. Batalden PB, Stoltz PK. A framework for the continual improvement of health care: building and applying professional improvement knowledge to test changes in daily work. Joint Commission J Qual Improve. 1993;19:424-445.
13. Walton M. The Deming Management Method. New York, NY: Perigee Books; 1986.
14. Tilley BC, NINDS t-PA Trial Investigators. A Deming approach to recruiting: the National Institute of Neurological Disorders and Stroke Trial experience. In: del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic Therapy in Acute Ischemic Stroke II. Berlin, Germany: Springer-Verlag; 1993:282-284. Abstract.
15. Barsan W, Brott T, Broderick J, Haley E, Levy D, Marler J. Time of hospital presentation of patients with acute stroke. Arch Intern Med. 1993;153:2558-2561.
16. Timerding BL, Barsan WG, Hedges JR, et al. Stroke patient evaluation in the emergency department before pharmacologic therapy. Am J Emerg Med. 1989;7:11-15.
17. Anderson NE, Broad JB, Bonita R. Delays in hospital admission and investigation in acute stroke. BMJ. 1995;311:162.
18. Kaste M, Palomaki H, Sarna S. Where and how should elderly stroke patients be treated? A randomized trial. Stroke. 1995;26:249-253.
19. Davalos A, Castillo J, Martinez-Vila E, for the Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Delay in neurological attention and stroke outcome. Stroke. 1995;26:2233-2237.
20. Malik MM, Gomez CR, Tulyapronchote R, Malkoff MD. Delay between emergency room arrival and stroke consultation. J Stroke Cerebrovasc Dis. 1993;3: 177-180.
21. Alberts MJ, Brass LM, Perry A, Webb D, Dawson DV. Evaluation times for patients with in-hospital strokes. Stroke. 1993;24:1817-1822.
22. Brott T, Haley ECJ, Levy DE, et al. Urgent therapy for stroke, I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23: 632-640.
23. Brott TG, Haley EC, Levy D, Barsan WC, Broderick J, Marier JR. Thrombolytic therapy in acute ischemic stroke. In: Hacke W, del Zoppo GJ, Mori E, eds. Strategies for Early Treatment of Acute Cerebral Infarction. Berlin, Germany: Springer-Verlag; 1991:197-203.
24. Gomez CR, Malkoff MD, Sauer CM, Tulyapronchote R, Burch C, Banet GA. Code Stroke: an attempt to shorten in-hospital therapeutic delays. Stroke. 1994;25: 1920-1923.
25. Sharkey SW, Brunette DD, Ruiz E, et al. An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA. 1989;262:3171-3174.
26. Kereiakes DJ, Weaver WD, Anderson JL, et al. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Am Heart J. 1990; 120:773-780.
27. Lyden PD, Rapp K, Babcock T, Rothrock J. Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials. J Stroke Cerebrovasc Dis. 1994; 4:106-113.